Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3-Reference-Cited by-同舟云学术

Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3

Published:2019-07 Issue:4 Volume:8 Page:206-211
ISSN:2213-2945
Container-title:Journal of the American Society of Cytopathology
language:en
Short-container-title:Journal of the American Society of Cytopathology

Author:

Wu Tao,Chen Xiangbai,Zheng Baowen,Li Juan,Xie Fengxiang,Ding Xiangdong,Zeng Zhengyu,Zhao Chengquan

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference21 articles.

1. Cervical cytology reporting rates from China's largest College of American Pathologists-certified laboratory with a focus on squamous cell carcinoma cytology and Its histopathological follow-up results;Zheng;Acta Cytol,2015

2. The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women;Benard;Cancer Causes Control,2015

3. The natural history of cervical human papillomavirus infections and cervical cancer: gaps in knowledge and future horizons;Wheeler;Obstet Gynecol Clin North Am,2013

4. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China;Xu;Oncotarget,2016

5. Bethesda System reporting rates for conventional Papanicolaou tests and liquid-based cytology in a large Chinese, College of American Pathologists-certified independent medical laboratory: analysis of 1,394,389 Papanicolaou test reports;Zheng;Arch Pathol Lab Med,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of the viral load of high-risk HPV in the diagnosis and prediction of cervical lesions: a retrospective study;BMC Women's Health;2021-10-08

2. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs;BMC Cancer;2020-08-26